SCHEMBL16627090

SCHEMBL16627090

CCOC(=P)Cc1c(O)nc2ccccc2c1-c1cccc(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.45
CYP3A4 P08684 5/20 0.45
CYP2C9 P11712 4/20 0.45
CYP2B6 P20813 2/20 0.45
AHR P35869 2/20 0.45
NR1I3 Q14994 2/20 0.45
VDR P11473 1/20 0.45
ADORA2A P29274 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.42
CYP2D6 P10635 4/20 0.42
KMT2A Q03164 3/20 0.42
USP2 O75604 3/20 0.42
CYP2C19 P33261 3/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CLK4 Q9HAZ1 2/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16627091 0.90 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL16624692 0.88 KMT2A (0.47) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL16627093 0.86 MEN1 (0.43) SMN1; SMN2KMT2AUSP2LMNAALDH1A1
SCHEMBL16624714 0.84 SMN1; SMN2 (0.55) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL20216022 0.83 CYP1A2 (0.48) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL20216025 0.82 ALDH1A1 (0.45) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL16624695 0.79 PDE4B (0.48) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL16624736 0.75 ALDH1A1 (0.49) CYP1A2CYP3A4CYP2C9SMN1; SMN2CYP2D6
SCHEMBL601233 0.75 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9CYP2B6AHR
SCHEMBL29587463 0.75 CYP1A2 (0.64) CYP1A2CYP3A4CYP2C9CYP2B6AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015051044-A2 NOVEL FORMATS FOR ORGANIC COMPOUNDS FOR USE IN RNA INTERFERENCE NOVARTIS AG (CH) 2015-04-09 WO disclosed